Advertisement
Hospital admission policy in Dismaland

Hospital admission policy in Dismaland

By Merrill Goozner  |  August 29, 2015

Over the several years that the CMS and hospitals have been tussling over the reasons behind the steady rise in short-term observation stays, no one until now has suggested the increase represents a deliberate effort by hospitals to avoid Medicare's 30-day readmission penalties.

Editorial: Moving beyond a sterile reform debate

Editorial: Moving beyond a sterile reform debate

By Merrill Goozner  |  August 22, 2015

The latest Kaiser Family Foundation tracking poll showed most Americans are more concerned about the rising price of drugs than repeal of the Affordable Care Act. But drug prices are not the only cost issue on peoples' minds.

Off-label drug marketing: another nail in the cost-control coffin

Off-label drug marketing: another nail in the cost-control coffin

By Merrill Goozner  |  August 15, 2015

Anyone concerned about unnecessary healthcare spending—and what system leader or insurer isn't these days?—should pay close attention to the drug industry's campaign to win the right to promote the off-label use of prescription drugs.

The world isn't waiting for better healthcare quality measures

The world isn't waiting for better healthcare quality measures

By Merrill Goozner  |  August 08, 2015

It doesn't matter how much healthcare providers and researchers rail about the inadequacy and inconsistency of the consumer ratings offered by the CMS, the Leapfrog Group, journalism outfits and online startups. They are not only here to stay, they are proliferating.

Editorial: The benefits of rate regulation

Editorial: The benefits of rate regulation

By Merrill Goozner  |  August 01, 2015

In what must have been a terrible disappointment for Obamacare bashers on the presidential campaign trail, the early returns from California suggest the rate increases next year in the individual and small-group health insurance market will be modest. The news comes with a caveat: Everything may...

Editorial: Think big on healthcare finance reform

Editorial: Think big on healthcare finance reform

By Merrill Goozner  |  July 25, 2015

The United States finances healthcare through a confusing hodgepodge of payment programs that send distorted signals to employers, insurers, providers and the general public.

Editorial: When it comes to care, there's no place like home

Editorial: When it comes to care, there's no place like home

By Merrill Goozner  |  July 18, 2015

Most senior citizens will fight fiercely to remain in their own homes, often well beyond their physical or even mental capacity to take care of themselves. A recent ACA-initiated demonstration program suggests there may be savings for Medicare if that's where seniors receive care.

Editorial: Save AHRQ; spend more on delivery system R&D

Editorial: Save AHRQ; spend more on delivery system R&D

By Merrill Goozner  |  July 04, 2015

For decades, the nation has poured hundreds of billions of dollars into basic and applied science to devise cures for diseases. But investing in research and development for new and better ways of delivering care in hospitals and physician offices remains a stepchild in Washington.

Editorial: The ACA's new political landscape

Editorial: The ACA's new political landscape

By Merrill Goozner  |  June 27, 2015

The healthcare industry heaved a collective sigh of relief last week after the U.S. Supreme Court upheld insurance subsidies in states using federally run exchanges. The 6-3 decision effectively puts an end to legal challenges to the Affordable Care Act.

Editorial: New approaches to community benefit needed

Editorial: New approaches to community benefit needed

By Merrill Goozner  |  June 20, 2015

Every once in a while, a study comes along that reminds us that a majority of the institutions we cover at Modern Healthcare are not-for-profits operating under government charters that absolve them from paying federal, state and local taxes.

No calm before the storm

No calm before the storm

By Merrill Goozner  |  June 13, 2015

The skirmishing ahead of the U.S. Supreme Court's King v. Burwell decision suggests we are in for a period of prolonged political turbulence should the high court strike down premium subsidies in the 34 states using the federally run exchanges.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.